{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:12:39Z","timestamp":1794474759679,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.dsx.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T13:49:33Z","timestamp":1539179373000},"page":"364-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":392,"title":["Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention"],"prefix":"10.1016","volume":"13","author":[{"given":"Sin Yee","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Ling","family":"Mei Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Jinn","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Sie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa Abdelgadir","family":"Mohamed Elhassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Pei","family":"Ling Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Wuen","family":"Rong Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveenya Chetty","family":"Annan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrat Kumar","family":"Bhattamisra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuren","family":"Candasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.10.008_bib1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.dsx.2018.06.021","article-title":"Current status of stem cell therapy, scaffolds for the treatment of diabetes mellitus","volume":"12","author":"Gharravi","year":"2018","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib2","article-title":"Type 1 diabetes is still linked to lower life expectancy","volume":"1","author":"Wise","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.dsx.2018.10.008_bib3","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.dsx.2016.12.022","article-title":"Diabetes microvascular complications\u2014a clinical update","volume":"11","author":"Khalil","year":"2017","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib4","article-title":"Complications of diabetes","volume":"2015","author":"Papatheodorou","year":"2015","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.dsx.2018.10.008_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.dsx.2015.04.002","article-title":"The diabetic foot","volume":"10","author":"Ahmad","year":"2016","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.dsx.2018.06.007","article-title":"Impacts of self-management education on glycaemic control in patients with type 2 diabetes mellitus","volume":"12","author":"Abdulah","year":"2018","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00381","article-title":"From diabetes care to diabetes cure-the integration of systems biology, ehealth, and behavioral change","volume":"8","author":"van Ommen","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.dsx.2018.10.008_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.dsx.2016.09.003","article-title":"Glucagon like peptide-1 and its receptor agonists: their roles in management of Type 2 diabetes mellitus","volume":"11","author":"Gupta","year":"2017","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib9","first-page":"1","article-title":"Recent trends in therapeutic approaches for diabetes management: a comprehensive update","author":"Tiwari","year":"2015","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.dsx.2018.10.008_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.dsx.2016.08.005","article-title":"Role of pancreatic duct cell in beta cell neogenesis: a mini review study","volume":"11","author":"Zare","year":"2017","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2017.03.008","article-title":"Long-term efficacy and safety of insulin and glucokinase gene therapy for diabetes: 8-Year Follow-Up in Dogs","volume":"6","author":"Ja\u00e9n","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.dsx.2018.10.008_bib12","first-page":"698","article-title":"Epidemiology of diabetes","volume":"42","author":"Forouhi","year":"2014","journal-title":"Med (United Kingdom)"},{"key":"10.1016\/j.dsx.2018.10.008_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/10408363.2018.1480591","article-title":"HbA1c method performance: the great success story of global standardization","volume":"55","author":"English","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.dsx.2018.10.008_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s001250051573","article-title":"Diabetes and gender","volume":"44","author":"Gale","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2018.10.008_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/2249-4863.154628","article-title":"Childhood obesity: causes and consequences","volume":"4","author":"Bhadoria","year":"2015","journal-title":"J\u00a0Fam Med Prim Care"},{"key":"10.1016\/j.dsx.2018.10.008_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.mjt.0000178767.67857.63","article-title":"Autoimmune destruction of pancreatic \u03b2 cells","volume":"12","author":"Yoon","year":"2005","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.dsx.2018.10.008_bib17","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/dc06-0974","article-title":"Breast-feeding and risk for childhood obesity: does maternal diabetes or obesity status matter?","volume":"29","author":"Mayer-Davis","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.10.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0179647","article-title":"Gestational diabetes mellitus and risk of type 2 diabetes 10 years after the index pregnancy in Sri Lankan women\u2014a community based retrospective cohort study","volume":"12","author":"Herath","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.dsx.2018.10.008_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11892-014-0492-2","article-title":"Lipotoxicity in the pancreatic beta cell: not just survival and function, but proliferation as well?","volume":"14","author":"Sharma","year":"2014","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/j.dsx.2018.10.008_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a007781","article-title":"Antigen targets of type 1 diabetes autoimmunity","volume":"2","author":"Roep","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.dsx.2018.10.008_bib21","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.2337\/db08-1007","article-title":"Big mac attack: does it play a direct role for monocytes\/macrophages in type 1 diabetes?","volume":"57","author":"Yang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00125-016-4197-8","article-title":"Glucose and fatty acids synergistically and reversibly promote beta cell proliferation in rats","volume":"60","author":"Moull\u00e9","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2018.10.008_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.11613\/BM.2013.033","article-title":"Diabetes and beta cell function: from mechanisms to evaluation and clinical implications","volume":"23","author":"Cernea","year":"2013","journal-title":"Biochem Med"},{"key":"10.1016\/j.dsx.2018.10.008_bib24","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-17-0042","article-title":"Pancreatic islet inflammation: an emerging role for chemokines","volume":"59","author":"Collier","year":"2017","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.dsx.2018.10.008_bib25","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2337\/db05-1615","article-title":"Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle","volume":"55","author":"Mas","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1463-1326.2000.00059.x","article-title":"Fatty acids and insulin secretion","volume":"2","author":"Amery","year":"2000","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2018.10.008_bib27","first-page":"25","article-title":"Stress and the inflammatory process\u202f: a major cause of pancreatic cell death in type 2 diabetes","volume":"7","author":"Montane","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.dsx.2018.10.008_bib28","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1038\/emm.2016.6","article-title":"Pancreatic regulation of glucose homeostasis","volume":"48","author":"R\u00f6der","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.dsx.2018.10.008_bib29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/ijo.2012.208","article-title":"Incretin hormones and the satiation signal","volume":"37","author":"Holst","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/j.dsx.2018.10.008_bib30","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/j.dsx.2017.03.006","article-title":"Signaling pathways linking inflammation to insulin resistance","volume":"11","author":"Zand","year":"2017","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ijo.2014.174","article-title":"Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity","volume":"39","author":"Xu","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/j.dsx.2018.10.008_bib32","doi-asserted-by":"crossref","first-page":"45304","DOI":"10.1074\/jbc.C400186200","article-title":"Protein kinase C \u03b8 inhibits insulin signaling by phosphorylating IRS1 at Ser1101","volume":"279","author":"Li","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dsx.2018.10.008_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/self.1.3.12643","article-title":"Gene therapy in diabetes","volume":"1","author":"Wong","year":"2010","journal-title":"Self Nonself"},{"key":"10.1016\/j.dsx.2018.10.008_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6750-12-64","article-title":"Evaluation of insulin expression and secretion in genetically engineered gut K and L-cells","volume":"12","author":"Ahmad","year":"2012","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.dsx.2018.10.008_bib35","first-page":"319","article-title":"Restoring insulin production for type 1 diabetes","volume":"4","author":"Tudur\u00ed","year":"2012","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MED.0000000000000174","article-title":"Pancreatic islet cell development and regeneration","volume":"22","author":"Romer","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.dsx.2018.10.008_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11373-008-9233-3","article-title":"Adeno-associated virus-mediated pancreatic and duodenal homeobox gene-1 expression enhanced differentiation of hepatic oval stem cells to insulin-producing cells in diabetic rats","volume":"15","author":"Li","year":"2008","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.dsx.2018.10.008_bib38","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1242\/dev.127.16.3533","article-title":"Expression of neurogenin3 reveals an islet cell precursor population in the pancreas","volume":"127","author":"Schwitzgebel","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.dsx.2018.10.008_bib39","first-page":"196","article-title":"Directed differentiation of progenitor cells towards an islet-cell phenotype","volume":"1","author":"Abed","year":"2012","journal-title":"Am J Stem Cells"},{"key":"10.1016\/j.dsx.2018.10.008_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0002666","article-title":"Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells","volume":"3","author":"Zhao","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.dsx.2018.10.008_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/19382014.2015.1075687","article-title":"Transcription factor regulation of pancreatic organogenesis, differentiation and maturation","volume":"8","author":"Dassaye","year":"2016","journal-title":"Islets"},{"key":"10.1016\/j.dsx.2018.10.008_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pgen.1003278","article-title":"Regulation of neurod1 contributes to the lineage potential of neurogenin3+ endocrine precursor cells in the pancreas","volume":"9","author":"Mastracci","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.dsx.2018.10.008_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4236\/jdm.2015.54037","article-title":"Genetic engineering of surrogate \u03b2 cells for treatment of type 1 diabetes mellitus","volume":"5","author":"Handorf","year":"2015","journal-title":"J\u00a0Diabetes Mellitus"},{"key":"10.1016\/j.dsx.2018.10.008_bib44","first-page":"37","article-title":"Insulin gene therapy for type 1 diabetes mellitus","volume":"13","author":"Handorf","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.dsx.2018.10.008_bib45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4914(02)02279-7","article-title":"Recent advances in insulin gene therapy for type 1 diabetes","volume":"8","author":"Yoon","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.dsx.2018.10.008_bib46","first-page":"1","article-title":"Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model","volume":"3","author":"Chen","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.dsx.2018.10.008_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrendo.2009.276","article-title":"Stem cell and gene therapies for diabetes mellitus","volume":"6","author":"Calne","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.dsx.2018.10.008_bib48","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db10-0084","article-title":"\u03b2-cell growth and regeneration: replication is only part of the story","volume":"59","author":"Bonner-Weir","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib49","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.molmet.2014.01.010","article-title":"Islet cell plasticity and regeneration","volume":"3","author":"Migliorini","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/j.dsx.2018.10.008_bib50","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jdi.12475","article-title":"\u03b2-Cell regeneration through the transdifferentiation of pancreatic cells: pancreatic progenitor cells in the pancreas","volume":"7","author":"Kim","year":"2016","journal-title":"J\u00a0Diabetes Investig"},{"key":"10.1016\/j.dsx.2018.10.008_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cmet.2017.08.007","article-title":"Pancreatic \u03b2 Cell regeneration as a possible therapy for diabetes","volume":"27","author":"Aguayo-Mazzucato","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.dsx.2018.10.008_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-213X-10-38","article-title":"Exocrine-to-endocrine differentiation is detectable only prior to birth in the uninjured mouse pancreas","volume":"10","author":"Kopinke","year":"2010","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.dsx.2018.10.008_bib53","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/stem.1676","article-title":"Human adipose-derived stromal\/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors","volume":"32","author":"Kono","year":"2014","journal-title":"Stem Cell"},{"key":"10.1016\/j.dsx.2018.10.008_bib54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/bdrc.20156","article-title":"Pancreas cell fate","volume":"87","author":"Guney","year":"2009","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.dsx.2018.10.008_bib55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.32607\/20758251-2010-2-2-18-27","article-title":"Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine","volume":"2","author":"Medvedev","year":"2010","journal-title":"Acta Naturae"},{"key":"10.1016\/j.dsx.2018.10.008_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","article-title":"Genetic and epigenetic variations in iPSCs: potential causes and implications for application","volume":"13","author":"Liang","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.dsx.2018.10.008_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/gb-2012-13-10-251","article-title":"The roles of the reprogramming factors Oct4, Sox2 and Klf4 in resetting the somatic cell epigenome during induced pluripotent stem cell generation","volume":"13","author":"Schmidt","year":"2012","journal-title":"Genome Biol"},{"key":"10.1016\/j.dsx.2018.10.008_bib58","article-title":"Analysis of embryoid bodies derived from human induced pluripotent stem cells as a means to assess pluripotency","volume":"1\u20139","author":"Sheridan","year":"2012","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.dsx.2018.10.008_bib59","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.molmet.2017.06.019","article-title":"Human beta cell mass and function in diabetes: recent advances in knowledge and technologies to understand disease pathogenesis","volume":"6","author":"Chen","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.dsx.2018.10.008_bib60","first-page":"1","article-title":"Generation of stem cell-derived \u03b2-cells from patients with type 1 diabetes","volume":"7","author":"Millman","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.dsx.2018.10.008_bib61","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jacbts.2016.06.010","article-title":"The promise and challenge of induced pluripotent stem cells for cardiovascular applications","volume":"1","author":"Youssef","year":"2016","journal-title":"JACC Basic to Transl Sci"},{"key":"10.1016\/j.dsx.2018.10.008_bib62","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5966\/sctm.2014-0248","article-title":"Concise review: new insights into the role of macrophages in \u03b2-cell proliferation","volume":"4","author":"Xiao","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.dsx.2018.10.008_bib63","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3109\/14653249.2010.509546","article-title":"Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules","volume":"12","author":"Kadam","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.dsx.2018.10.008_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-017-0233-1","article-title":"Mesenchymal stem cell therapy in type 2 diabetes mellitus","volume":"9","author":"Zang","year":"2017","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.dsx.2018.10.008_bib65","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000448180","article-title":"Adipose tissue-derived stem cells in regenerative medicine","volume":"43","author":"Frese","year":"2016","journal-title":"Transfus Med Hemotherapy"},{"key":"10.1016\/j.dsx.2018.10.008_bib66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gene.2018.02.008","article-title":"Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus","volume":"654","author":"Amer","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.dsx.2018.10.008_bib67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1507\/endocrj.EJ14-0584","article-title":"Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats","volume":"62","author":"Hu","year":"2015","journal-title":"Endocr J"},{"key":"10.1016\/j.dsx.2018.10.008_bib68","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.bbrc.2013.10.059","article-title":"Transplantation of insulin-secreting cells differentiated from human adipose tissue-derived stem cells into type 2 diabetes mice","volume":"443","author":"Nam","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.dsx.2018.10.008_bib69","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/stemcells.2004-0123","article-title":"Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and\/or microenvironmental manipulation in\u00a0vitro","volume":"23","author":"Moriscot","year":"2005","journal-title":"Stem Cell"},{"key":"10.1016\/j.dsx.2018.10.008_bib70","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.diff.2009.01.001","article-title":"Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in\u00a0vitro","volume":"77","author":"Xie","year":"2009","journal-title":"Differentiation"},{"key":"10.1016\/j.dsx.2018.10.008_bib71","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1089\/ten.tea.2008.0579","article-title":"Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells","volume":"15","author":"Wu","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.dsx.2018.10.008_bib72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11684-011-0116-z","article-title":"Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study","volume":"5","author":"Jiang","year":"2011","journal-title":"Front Med"},{"key":"10.1016\/j.dsx.2018.10.008_bib73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/dmt.10.24","article-title":"Mechanisms in the adaptation of maternal \u03b2-cells during pregnancy","volume":"1","author":"Ernst","year":"2011","journal-title":"Diabetes Manag"},{"key":"10.1016\/j.dsx.2018.10.008_bib74","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3945\/an.113.005488","article-title":"Pancreatic \u03b2-cell proliferation in obesity","volume":"5","author":"Linnemann","year":"2014","journal-title":"Adv Nutr"},{"key":"10.1016\/j.dsx.2018.10.008_bib75","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1172\/JCI87439","article-title":"Advances in \u03b2 cell replacement and regeneration strategies for treating diabetes","volume":"126","author":"Benthuysen","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.dsx.2018.10.008_bib76","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","article-title":"Negative feedback regulation of the ERK1\/2 MAPK pathway","volume":"73","author":"Lake","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.dsx.2018.10.008_bib77","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.2337\/db12-0018","article-title":"Human \u03b2-cell proliferation and intracellular signaling: driving in the dark without a road map","volume":"61","author":"Kulkarni","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib78","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group","volume":"281","author":"Turner","year":"1999","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.dsx.2018.10.008_bib79","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2337\/dc15-0168","article-title":"Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology","volume":"38","author":"Heinemann","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.10.008_bib80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jphp.12852","article-title":"Oral insulin delivery: existing barriers and current counter-strategies","volume":"70","author":"Gedawy","year":"2018","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.dsx.2018.10.008_bib81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.dsx.2018.10.008_bib82","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4578","article-title":"Effect of metformin monotherapy on serum lipid profile in statin-na\u00efve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study","volume":"6","author":"Lin","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.dsx.2018.10.008_bib83","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"Suppl 3","key":"10.1016\/j.dsx.2018.10.008_bib84","doi-asserted-by":"crossref","first-page":"S368","DOI":"10.2337\/diabetes.51.2007.S368","article-title":"Sulfonylurea stimulation of insulin secretion","volume":"51","author":"Proks","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib85","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5114\/aoms.2015.53304","article-title":"Sulfonylureas and their use in clinical practice","volume":"11","author":"Sola","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.dsx.2018.10.008_bib86","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-157-9-201211060-00003","article-title":"Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus","volume":"157","author":"Roumie","year":"2012","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.dsx.2018.10.008_bib87","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.2337\/dcS13-2003","article-title":"In\u00a0vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion","volume":"36","author":"Eldor","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.10.008_bib88","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.2337\/db13-0265","article-title":"Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates","volume":"62","author":"DeFronzo","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib89","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1152\/ajpendo.00551.2006","article-title":"Thiazolidinediones improve beta-cell function in type 2 diabetic patients","volume":"292","author":"Gastaldelli","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.10.008_bib90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0976-500X.179363","article-title":"Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction","volume":"7","author":"Jearath","year":"2016","journal-title":"J\u00a0Pharmacol Pharmacother"},{"key":"10.1016\/j.dsx.2018.10.008_bib91","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4103\/2230-8210.141319","article-title":"Dipeptidyl peptidase-4 inhibitors: novel mechanism of actions","volume":"18","author":"Singh","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2018.10.008_bib92","first-page":"509","article-title":"Dipeptidyl peptidase-4 (DPP-4) inhibitors in the management of diabetes","volume":"35","author":"Pathak","year":"2010","journal-title":"Pharm Therapeut"},{"key":"10.1016\/j.dsx.2018.10.008_bib93","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/ijcp.12361","article-title":"GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?","volume":"68","author":"Brunton","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.dsx.2018.10.008_bib94","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2337\/dc11-0291","article-title":"Effects of exenatide on measures of \u03b2-cell function after 3 years in metformin-treated patients with type 2 diabetes","volume":"34","author":"Bunck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.10.008_bib95","first-page":"55","article-title":"Incretin-based therapies","volume":"4","author":"Stonehouse","year":"2012","journal-title":"J\u00a0Diabetes"},{"key":"10.1016\/j.dsx.2018.10.008_bib96","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1185\/030079908X253870","article-title":"Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years","volume":"24","author":"Klonoff","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.dsx.2018.10.008_bib97","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.10.008_bib98","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","article-title":"Sodium glucose Co-Transporter-2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology","volume":"5","author":"Kalra","year":"2014","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.dsx.2018.10.008_bib99","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/er.2010-0029","article-title":"Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes","volume":"32","author":"Abdul-Ghani","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/j.dsx.2018.10.008_bib100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.10.008_bib101","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/S0140-6736(14)61335-0","article-title":"Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis","volume":"384","author":"Eng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.dsx.2018.10.008_bib102","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1038\/s41598-018-22658-2","article-title":"Combination of sodium-glucose cotransporter 2 inhibitor and dipeptidyl peptidase-4 inhibitor in type 2 diabetes: a systematic review with meta-analysis","volume":"8","author":"Min","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.dsx.2018.10.008_bib103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(10)60746-5","article-title":"Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study","volume":"376","author":"Zinman","year":"2010","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1016\/j.dsx.2020.12.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118304181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118304181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:22:36Z","timestamp":1775244156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118304181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1871402118304181"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.10.008","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}